Skip to content

Public FDA record

Z-1324-2021: Precice Bone Transport - Product Usage: intended for limb lengthening, open and closed fracture fixatio

Recall record Z-1324-2021 for Nuvasive Specialized Orthopedics Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1324-2021
Company in FDA record
Nuvasive Specialized Orthopedics Inc
FDA classification date
Mar 30, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to complaints of adverse events potentially related to biological safety. The complaints included report of pain and bony abnormalities at the interface between the telescoping nail segments.

Source facts

Action
On 02/12/2021, the firm sent via email an "URGENT FIELD SAFETY NOTICE" that informed customers that There have been several reports of adverse events potentially related to biological safety in one of the device systems, which are currently under investigation. The events include reports of pain and bony abnormalities at the interface between the telescoping nail segments. The Recalling Firm is informing its customers that the affected devices are not indicated for use in individuals younger than 18 years of age and instructing/informing them: -That an Recalling Firm representative will be contacted their office or they will be provided instructions for returning the affected product. -To not implant the affected devices until further notice. -To review, complete, sign and return the Consignee Confirmation Form by scanning and emailing the form to FSNprecice@nuvasive.com. -The affected devices will not be available until further notice. -Prophylactic removal of functioning devices is not recommended. Instead, any treatment decisions should be made by the physician in consultation with the patient and/or family. -For any patients, assessment of any symptoms, via consultation, and radiography should be made to determine if pain and abnormal bony changes might be present, as described above. --- If so, then clinical care decisions should be made at the discretion of the healthcare team, in consultation with the patient and any other relevant decision makers. -If a patient has been previously implanted with the listed device and was under the age of 18, consultation may be warranted, at the discretion of the provider. -If a patient has been previously implanted with a listed device and is pregnant, becomes pregnant, or intends to become pregnant, consultation may be warranted, at the discretion of the provider. -Forward this notice to anyone in your facility that needs to be informed. -Direct any additional manufacturer inquiries to FSNprecice@nuvasive.co
Initiated
2021-02-12
Root cause
Under Investigation by firm
Distribution
Worldwide distribution - U.S. Nationwide distribution and the countries of Argentina, Austria, Belgium, Canada, Chile, Colombia, Cyprus, Denmark, Finland, France, Germany, Greece, Hong Kong, Israel, Italy, Luxemburg, Netherlands, Portugal, Saudi Arabia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey and UAE. Consignee List provided only includes email addresses. Complete contact information is pending.
Recall number
Z-1324-2021
Recall status
Open, Classified
CDRH record ID
185861
FDA classified
2021-03-30
Recall event number
87352

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗